Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Single Center Experience

This article has no abstract
Epistemonikos ID: c1bc88c3cc864368e1cc9e29cc4934ed9bd2a59e
First added on: Feb 16, 2025